
About Abgenex
Abgenex is a Healthcare company based in Bhubaneswar (India) founded in 2013 by Sujay Singh. Antibodies and molecular biology reagents are developed and manufactured. Its Indian entity Abgenex Private Limited reported revenue of βΉ1.35 Cr. Abgenex offers products and services including Antibodies, Cell Lines, Recombinant Proteins, and Research Kits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.
Company details
Abgenex was founded in 2013 and is based in Bhubaneswar, India. Operations focus on the biotechnology sector, where antibodies, molecular biology kits, cell lines, proteins, and tissue microarrays are developed and produced. Custom services are provided, including monoclonal and polyclonal antibody development, epitope design, peptide synthesis, stable cell line generation, protein production, and immunohistochemistry. Fast-track screening for monoclonal antibody production and in vitro drug discovery screening are also offered.
- Headquarters Bhubaneswar, India
- Founders Sujay Singh
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website abgenex.com
- Social LinkedIn X Facebook
- Legal Name Abgenex Private Limited
- Date of Incorporation 25 Nov, 2002
- Jurisdiction Bhubaneswar, Odisha, India
- Annual Revenue₹1.35 Cr
FY 2025 · +5% YoY
- Net Profit₹5.7 Lakh
FY 2025 · 4% margin
- EBITDA₹6.4 Lakh
FY 2025 · 5% margin
Associated legal entities of Abgenex
Abgenex operates through Abgenex Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abgenex Private Limited CIN U24239OR2002PTC006982 | Active | 25 Nov 2002 | Bhubaneswar, Odisha | ₹1.4 Cr | 2 | 5 | View details |
Products & Services of Abgenex
Abgenex offers a comprehensive portfolio of products and services, including Antibodies, Cell Lines, Recombinant Proteins, and Research Kits.
High-quality antibodies for research and diagnostics purposes
Stable cell lines for various biological assays and studies
Proteins for bio-activity assays and stem cell research
Kits for ELISA, apoptosis detection, and flow cytometry
Board of directors of Abgenex Private Limited (Abgenex)
Abgenex Private Limited is the primary company behind Abgenex. The board of Abgenex Private Limited currently have 5 directors; the longest-serving is Sujay Kumar Singh, appointed in 2002. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sujay Kumar Singh DIN 00616056 | Director | 25 Nov 2002 | 23 yrs 11 mo | Abgenex Private Limited |
| Gita Singh DIN 03625506 | Director | 02 Jan 2012 | 14 yrs 10 mo | Abgenex Private Limited |
| Subrat Kumar Kar DIN 06855597 | Director | 27 Feb 2015 | 11 yrs 8 mo | Abgenex Private Limited |
| Jabed Akhtar DIN 06855580 | Director | 27 Feb 2015 | 11 yrs 8 mo | Abgenex Private Limited |
| Prasanta Kumar Maiti DIN 06855565 | Director | 27 Jul 2018 | 8 yrs 3 mo | Abgenex Private Limited |
People of Abgenex
1 people are tracked at Abgenex (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & Director | Leadership |
Complete people profiles for Abgenex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Abgenex
Figures of Abgenex Private Limited, the primary company behind Abgenex, for FY 2025. Revenue was ₹1.35 Cr (+5% year on year). Net profit was ₹5.7 Lakh (4% margin). EBITDA was ₹6.4 Lakh (5% margin). Revenue has grown at a compounded annual rate of -5% over three years and +7% over five years.
- ₹1.35 CrRevenue · FY 2025 · +5% YoY
- ₹5.7 LakhNet profit · 4% margin
- ₹6.4 LakhEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- 2Employees (provident fund records)
- -5%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abgenex Private Limited are on its company page.
Detailed financial statements for Abgenex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Abgenex
The website of Abgenex (abgenex.com) receives about 4.4K visits a month.
- Monthly visits4.4K
▲ 3.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abgenex
Abgenex was founded in 2013.
Abgenex is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.
The primary company behind Abgenex, Abgenex Private Limited, reported revenue of βΉ1.35 Cr for FY 2025, up 5% year on year.
Abgenex was founded in 2013 and is based in Bhubaneswar, India. Operations focus on the biotechnology sector, where antibodies, molecular biology kits, cell lines, proteins, and tissue microarrays are developed and produced. Custom services are provided, including monoclonal and polyclonal antibody development, epitope design, peptide synthesis, stable cell line generation, protein production, and immunohistochemistry. Fast-track screening for monoclonal antibody production and in vitro drug discovery screening are also offered.
Abgenex offers Antibodies, Cell Lines, Recombinant Proteins, and Research Kits.
Abgenex operates through Abgenex Private Limited.
The legal entities of Abgenex currently have 5 directors, including Gita Singh, Subrat Kumar Kar, Prasanta Kumar Maiti and others.